Post-IPO Equity - Neuronetics
Investment Firm
Overview
Neuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.
Announced Date
Jun 27, 2022
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 J Carlo Cannell |
Round Details and Background
Neuronetics raised an undisclosed amount on 2022-06-27 in Post-IPO Equity
Neuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.
Company Funding History
12
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 17, 2006 |  Series C - Neuronetics | 6 | - | 35.0M |
| Apr 27, 2015 | Series F - Neuronetics | 9 | - | 34.3M |
| May 16, 2011 | Series E - Neuronetics | 8 | - | 30.0M |
| Oct 27, 2009 | Series D - Neuronetics | 8 | - | 30.0M |
Recent Activity
There is no recent news or activity for this profile.